Eucomed demands swift action from Commission after review agreement
This article was originally published in Clinica
Executive Summary
The European Commission needs to take swift action to introduce amendments to the medical device directives to cover all products containing human derived cells and tissues which will not be included within the scope of the proposed Advanced Therapy Medicinal Products Regulation.